Sylvant is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Sylvant is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameSylvant
Authorized genericsiltuximab
Regular genericsiltuximab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Sylvant?
The original
–
–

Brand nameThe maker’s card

SYLVANT Financial Assistance (RRD Patient Solutions)

Savings card from Recordati Rare Diseases

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 an infusion

Sign up on sylvant.com 

Or call 1-855-299-8844.

In the maker’s words

“Eligible patients pay as little as $0 per infusion…”

From the maker’s offer on sylvant.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Sylvant itself, from the same company, sold without the brand name, and usually for less. For now Sylvant is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Sylvant is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

SYLVANT is an interleukin-6 (IL-6) antagonist indicated for the treatment of patients with multicentric Castleman's disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative.

Limitations of Use

SYLVANT was not studied in patients with MCD who are HIV positive or HHV-8 positive because SYLVANT did not bind to virally produced IL-6 in a nonclinical study.

Source: the FDA label for Sylvant (Recordati Rare Diseases, Inc.), August 27, 2024. Full label on DailyMed 

Good to know